Ventas Inc (VTR)

NYSE · Real Estate · REIT - Healthcare Facilities · USA

Ventas Inc is a large cap company (market value between $10 billion and $200 billion) in the REIT - Healthcare Facilities industry.

Ventas is a real estate investment trust holding senior housing communities, medical office properties, research facilities and healthcare buildings primarily across North America and the United Kingdom. The company operates three segments: senior housing operations, medical and research assets, and triple-net leased properties, working with external managers and institutional capital partners.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Ventas Inc stock.

Our verdict on VTR

Overvalued: intrinsic value $26.18 per share, market price $84.51, margin of safety -222.8% (as of 2026-10-19).

Discounting its cash flows at 8.5% (average of 2 methods) values the shares at $26.18; the price of $84.51 is 223% above that value.

Leak Score: 31/100 on 10 of 12 signals (On Watch).

ETFs with the most weight in VTR

17 more funds hold it; the full list is part of the paid plan.

More on VTR

Browse

Peers in REIT - Healthcare Facilities

All 17 REIT - Healthcare Facilities stocks

Compare side by side

Cheaper than VTR in REIT - Healthcare Facilities

9 more in this industry show a wider margin of safety.

Is VTR undervalued or overvalued?

VTR is overvalued (as of the 2026-10-19 close). Discounting its cash flows at 8.5% (average of 2 methods) values the shares at $26.18; the price of $84.51 is 223% above that value.

What is the intrinsic value of VTR?

$26.18 per share (as of the 2026-10-19 close), against a market price of $84.51. That is a margin of safety of -222.8%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.

What is Ventas Inc's Leak Score?

31 out of 100, which we rate "On Watch", on 10 of 12 value investing signals.